These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38625978)

  • 21. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
    Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
    J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma.
    Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J
    Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells.
    Zhai J; Luo G
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
    Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK/JUN-mediated aerobic glycolysis.
    Meng Z; Wang Y; Wang X; Han X
    Arch Oral Biol; 2024 Aug; 164():105977. PubMed ID: 38696945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LINC00664/miR-411-5p/KLF9 feedback loop contributes to the human oral squamous cell carcinoma progression.
    Wang C; Wang Q; Weng Z
    Oral Dis; 2023 Mar; 29(2):672-685. PubMed ID: 34582069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of tumor cell-derived TGF-β on macrophage phenotype and macrophage-mediated tumor cell invasion.
    Maldonado LAG; Nascimento CR; Rodrigues Fernandes NA; Silva ALP; D'Silva NJ; Rossa C
    Int J Biochem Cell Biol; 2022 Dec; 153():106330. PubMed ID: 36343916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
    Li X; Ren H
    Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
    Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
    BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PRELP inhibits the progression of oral squamous cell carcinoma via inactivation of the NF-κB pathway.
    Sun X; Chai L; Wang B; Zhou J
    Arch Oral Biol; 2024 Nov; 167():106068. PubMed ID: 39151326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
    Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
    Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naa10p and IKKα interaction regulates EMT in oral squamous cell carcinoma via TGF-β1/Smad pathway.
    Lv S; Luo T; Yang Y; Li Y; Yang J; Xu J; Zheng J; Zeng Y
    J Cell Mol Med; 2021 Jul; 25(14):6760-6772. PubMed ID: 34060226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
    Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
    J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXD1-AS1 upregulates FOXD1 to promote oral squamous cell carcinoma progression.
    Ma Y; Han J; Luo X
    Oral Dis; 2023 Mar; 29(2):604-614. PubMed ID: 34403535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway.
    Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X
    Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
    Sun MY; Wang L; Shen ZY
    Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FAM122A functions as a tumor suppressor in oral squamous cell carcinoma.
    Zhu H; Huang Y; Chen J
    Exp Cell Res; 2024 Aug; 441(2):114165. PubMed ID: 39009214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.